A new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy Stage Evaluation (PROMISE) application

Archive ouverte

Villeneuve, L. | Thivolet, A. | Bakrin, N. | Mohamed, F. | Isaac, S. | Valette, P.-J. | Glehen, O. | Rousset, P. | Abba, J. | Abboud, K. | Arvieux, C. | Balagué, G. | Barrau, V. | Rejeb, H.B. | Bereder, J.-M. | Bibeau, F. | Bouzard, D. | Brigand, C. | Carrere, S. | Carretier, M. | de Chaisemartin, C. | Chassang, M. | Chevallier, A. | Courvoisier, T. | Dartigues, P. | Delroeux, D. | Desolneux, G. | Dohan, A. | Dromain, C. | Dumont, F. | Durand-Fontanier, S. | Elias, D. | Eveno, C. | Evrard, S. | Fay, O. | Ferron, G. | Geffroy, D. | Gilly, F.-N. | Fontaine, Julien | Goasguen, N. | Ghouti, L. | Goéré, D. | Guilloit, J.-M. | Guyon, F. | Heyd, B. | Kaci, R. | Karoui, M. | Kianmanesh, R. | Labbé, C. | Lacroix, J. | Lang-Averous, G. | Laverrière, M.-H. | Lefevre, J. | Lelong, B. | Leroux, A. | Dico, R.L. | Loi, V. | Lorimier, G. | Marchal, F. | Mariani, A. | Mariani, P. | Mariette, C. | Méeus, P. | Mery, E. | Messager, M. | Msika, S. | Nadeau, C. | Ortega-Deballon, P. | Passot, G. | Petorin, C. | Peyrat, P. | Pezet, D. | Piessen, G. | Pirro, N. | Pocard, M. | Poizat, F. | Porcheron, J. | Pourcher, G. | Quenet, F. | Rat, P. | Régimbeau, Jean-Marc | Rousselot, P. | Sabbagh, Charles | Svrcek, M. | Tetreau, R. | Thibaudeau, E. | Tuech, J.-J. | Valmary-Degano, S. | Vaudoyer, D. | Velasco, S. | Verriele-Beurrier, V. | Wernert, R. | Zinzindohoue, F.

Edité par CCSD ; WB Saunders -

International audience. Based on the importance of assessing the true extent of peritoneal disease, PeRitOneal MalIgnancy Stage Evaluation (PROMISE) internet application (www.e-promise.org) has been developed to facilitate tabulation and automatically calculate surgically validated peritoneal cancer index (PCI), and other surgically validated scores as Gilly score, simplified peritoneal cancer index (SPCI), Fagotti and Fagotti-modified scores. This application offers computer-assistance to produce simple, quick but precise and standardized pre, intra and postoperative reports of the extent of peritoneal metastases and may help specialized and non-specialized institutions in their current practice but also facilitate research and multicentre studies on peritoneal surface malignancies.

Consulter en ligne

Suggestions

Du même auteur

Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: A RENAPE study

Archive ouverte | Valmary-Degano, S. | CCSD

International audience. BACKGROUND:Epithelioid peritoneal malignant mesothelioma (EPMM) is the most common subtype of this aggressive tumor. We compared two antibodies against PD-L1, a recent theranostic biomarker, ...

Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): A French multicentric survey

Archive ouverte | Ferron, G. | CCSD

International audience. BACKGROUND:Over the last two decades, many surgical teams have developed programs to treat peritoneal carcinomatosis with extensive cytoreductive surgery and hyperthermic intraperitoneal chem...

Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups

Archive ouverte | Glehen, O. | CCSD

International audience

Chargement des enrichissements...